Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

Seneca Biopharma, Germantown, Md., issued a press release announcing its recent meeting with the FDA to discuss elements of a final design and protocol for a Phase 3 trial investigating…

Continue Reading Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis
Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
Free-Photos / Pixabay

Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease

According to an article in The Asahi Shimbun, Japanese scientists have developed a new vaccine to mitigate neuronal degeneration caused by Alzheimer's disease. The vaccine, delivered nasally, had promising results…

Continue Reading Nasal Vaccine Prevents Neuronal Loss in Mice Models of Alzheimer’s Disease
An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials
Pixabay

An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

Ornithine transcarbamylase (OTC) deficiency is a disorder that can cause comas, seizures, and death, making it necessary for those affected to seek treatment. Arcturus Therapeutics aims to give those with…

Continue Reading An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient

According to a report by ABC News, Virtua Health, one of the largest healthcare providers in New Jersey, claimed to have a forty-year history of organ transplant completions. Nonetheless, a…

Continue Reading He Waited Five Years to Receive a Kidney Transplant and Then the Kidney Was Given to the Wrong Patient
“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
source: pixabay.com

“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes

  A person with diabetes is not able to properly make or use insulin well. Advancements in science are now seriously looking at updating and perfecting ways to help people…

Continue Reading “Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response

  According to new research from the Journal of Infectious Diseases, a new protein epitope has been discovered while testing the immune response of people with Kawasaki Disease. Kawasaki Disease, also…

Continue Reading New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
source: pixabay.com

FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever

A press release from the US Food and Drug Administration (FDA) recently announced the approval of the drug selumetinib (marketed as Koselugo) for the treatment of patients aged two years…

Continue Reading FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
source: pixabay.com

Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome

NICHD The NICHD is the The Eunice Kennedy Shriver National Institute of Child Health and Human Development, one of the National Institutes of Health (NIH). It is the center for…

Continue Reading Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
source: pixabay.com

Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong

  If you're worried or anxious because of COVID-19, you're not alone. If wondering about the intersection of rare diseases and COVID-19 only increases that anxiety, well, we're with you…

Continue Reading Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment
source: pixabay.com

FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment

According to a story from globenewswire.com, the biopharmaceutical company Liquidia Technologies, Inc. just announced that the company's New Drug Application (NDA) has been officially accepted by the US Food and…

Continue Reading FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment